Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN731528 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN731528, RRID:AB_11206720
- Product name
- anti-BCL2 Binding Component 3 (BBC3) (AA 120-170) antibody
- Antibody type
- Polyclonal
- Description
- Purified by Protein A.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- AA 120-170
- Isotype
- IgG
- Vial size
- 100 μL
- Storage
- Store at -20°C
Submitted references A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53.
Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Qiu S, Cai Y, Gao X, Gu SZ, Liu ZJ
Cancer letters 2015 Jan 28;356(2 Pt B):910-7
Cancer letters 2015 Jan 28;356(2 Pt B):910-7
Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P, Liu H, Xia F, Zhang QW, Zhang YY, Zhao Q, Chao ZH, Jiang ZW, Jiang CC
International journal of molecular medicine 2014 Jan;33(1):151-9
International journal of molecular medicine 2014 Jan;33(1):151-9
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS